ConductScience.org, home

Trial · NCT03157089

Adverse events216

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherAnaemiaBlood and lymphatic system disordersAfatinib 40 mg + Pembrolizumab 200 mg312
otherAnaemiaBlood and lymphatic system disordersAfatinib 30 mg + Pembrolizumab 200 mg312
otherAtrial fibrillationCardiac disordersAfatinib 40 mg + Pembrolizumab 200 mg112
otherAtrial fibrillationCardiac disordersAfatinib 30 mg + Pembrolizumab 200 mg012
otherHyperthyroidismEndocrine disordersAfatinib 40 mg + Pembrolizumab 200 mg212
otherHyperthyroidismEndocrine disordersAfatinib 30 mg + Pembrolizumab 200 mg212
otherHypothyroidismEndocrine disordersAfatinib 40 mg + Pembrolizumab 200 mg012
otherHypothyroidismEndocrine disordersAfatinib 30 mg + Pembrolizumab 200 mg212
otherAbdominal painGastrointestinal disordersAfatinib 40 mg + Pembrolizumab 200 mg112
otherAbdominal painGastrointestinal disordersAfatinib 30 mg + Pembrolizumab 200 mg112
otherCheilitisGastrointestinal disordersAfatinib 40 mg + Pembrolizumab 200 mg212
otherCheilitisGastrointestinal disordersAfatinib 30 mg + Pembrolizumab 200 mg012
otherConstipationGastrointestinal disordersAfatinib 40 mg + Pembrolizumab 200 mg112
otherConstipationGastrointestinal disordersAfatinib 30 mg + Pembrolizumab 200 mg012
otherDiarrhoeaGastrointestinal disordersAfatinib 40 mg + Pembrolizumab 200 mg1112
otherDiarrhoeaGastrointestinal disordersAfatinib 30 mg + Pembrolizumab 200 mg712
otherDyspepsiaGastrointestinal disordersAfatinib 40 mg + Pembrolizumab 200 mg112
otherDyspepsiaGastrointestinal disordersAfatinib 30 mg + Pembrolizumab 200 mg012
otherGastritisGastrointestinal disordersAfatinib 40 mg + Pembrolizumab 200 mg112
otherGastritisGastrointestinal disordersAfatinib 30 mg + Pembrolizumab 200 mg012

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03157089/events